Join
Live feed
·
PRReleasevia Quantisnow
Century Therapeutics Inc. logo

Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026

ByQuantisnow·Wall Street's wire, on your screen.
IPSC· Century Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IPSC (Century Therapeutics Inc.) and more on Quantisnow.